Literature DB >> 28492992

[Choosing wisely recommendations in gastroenterology].

H Koop1,2, P Lynen Jansen3, S Zeuzem4.   

Abstract

The Choosing wisely initiative of the German Society of Internal Medicine addresses procedures which are inadequately implemented (deficits in patient care) as well as those which are performed too often but without proven benefits for patients (misuse or overuse of health services). Based on their guidelines, The German Society of Gastroenterology, Digestive and Metabolic Diseases has identified such aspects and incorporated them into the respective recommendations.

Entities:  

Keywords:  Colorectal neoplasms; Crohn disease; Gallstones; Health services misuse; Liver cirrhosis

Mesh：

Year:  2017        PMID： 28492992     DOI： 10.1007/s00108-017-0245-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  26 in total

1.  Cause of death in patients with inflammatory bowel disease.

Authors:  C Cucino; A Sonnenberg
Journal:  Inflamm Bowel Dis       Date:  2001-08       Impact factor: 5.325

2.  [S3-guideline colorectal cancer version 1.0].

Authors:  C Pox; S Aretz; S C Bischoff; U Graeven; M Hass; P Heußner; W Hohenberger; A Holstege; J Hübner; F Kolligs; M Kreis; P Lux; J Ockenga; R Porschen; S Post; N Rahner; A Reinacher-Schick; J F Riemann; R Sauer; A Sieg; W Scheppach; W Schmitt; H J Schmoll; K Schulmann; A Tannapfel; W Schmiegel
Journal:  Z Gastroenterol       Date:  2013-08-16       Impact factor: 2.000

3.  [Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011].

Authors:  A Dignass; J C Preiss; D E Aust; F Autschbach; A Ballauff; G Barretton; B Bokemeyer; S Fichtner-Feigl; S Hagel; K R Herrlinger; G Jantschek; A Kroesen; W Kruis; T Kucharzik; J Langhorst; M Reinshagen; G Rogler; D Schleiermacher; C Schmidt; S Schreiber; H Schulze; E Stange; M Zeitz; J C Hoffmann; A Stallmach
Journal:  Z Gastroenterol       Date:  2011-08-24       Impact factor: 2.000

4.  [Updated German clinical practice guideline on "Diagnosis and treatment of Crohn's disease" 2014].

Authors:  J C Preiß; B Bokemeyer; H J Buhr; A Dignaß; W Häuser; F Hartmann; K R Herrlinger; B Kaltz; P Kienle; W Kruis; T Kucharzik; J Langhorst; S Schreiber; B Siegmund; A Stallmach; E F Stange; J Stein; J C Hoffmann
Journal:  Z Gastroenterol       Date:  2014-12-04       Impact factor: 2.000

5.  Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization.

Authors:  G D Friedman; C A Raviola; B Fireman
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

6.  [Smoking cessation in patients with COPD].

Authors:  S Andreas; A Batra; J Behr; J-F Chenot; A Gillissen; T Hering; F J F Herth; M Kreuter; R Meierjürgen; S Mühlig; D Nowak; M Pfeifer; T Raupach; K Schultz; H Sitter; J W Walther; H Worth
Journal:  Pneumologie       Date:  2014-02-25

7.  The natural history of gallstones: the GREPCO experience. The GREPCO Group.

Authors:  A F Attili; A De Santis; R Capri; A M Repice; S Maselli
Journal:  Hepatology       Date:  1995-03       Impact factor: 17.425

8.  Smoking cessation and the course of Crohn's disease: an intervention study.

Authors:  J Cosnes; L Beaugerie; F Carbonnel; J P Gendre
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

9.  Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study.

Authors:  Tiago Nunes; Maria Josefina Etchevers; Valle García-Sánchez; Daniel Ginard; Eva Martí; Manuel Barreiro-de Acosta; Fernando Gomollón; Maite Arroyo; Guillermo Bastida; Benito Gonzalez; David Monfort; Esther García-Planella; Carolina Figueroa; Julián Panés; Miquel Sans
Journal:  Am J Gastroenterol       Date:  2016-02-09       Impact factor: 10.864

10.  Safety of nonanesthetist sedation with propofol for outpatient colonoscopy and esophagogastroduodenoscopy.

Authors:  D Külling; R Rothenbühler; W Inauen
Journal:  Endoscopy       Date:  2003-08       Impact factor: 10.093
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.